Providing compliant, autonomous execution scientists can trust
Contact UsReinventing regulated science with AI-native workflows
Audit-ready by default
Intelligent agents automate
Deliver results faster
Biopharma clients since 2021
Decreased testing cycle time
To file with LiVeritas
Academic lab pricing and FDA-ready output in less than 5 days
Built by experts with 20+ INDs, 10 labs launched, and global compliance experience
Custom solutions aligned to each client’s specific needs
High-precision tech delivering reliable, reproducible results
AI-native workflows that cut costs and speed up submissions
Real feedback from professionals we’ve partnered with in the biopharma industry.
IND filing on time to enable Phase 1 human trials
Contract manufacturing confirmation
Lead drug validation process for scale-up
160% contract expansion mid-cycle
$1B+ valuation step function increase unlocked
Our experts have over 100 years of experience in delivering scientific excellence.
Co-Founder, CEO
Learn More
Co-Founder, Head of Research & Systems Integration
Learn More
Head of Software Engineering
Learn More
Chief of Staff
Learn More
Co-Founder, Legal Advisor
Learn More
Interview
November 22, 2024From selling candies in the Philippines to leading a biotech startup in California, Lieza Danan’s journey is one of resilience, vision, and scientific excellence. Now the CEO and co-founder of LiVeritas Biosciences, she’s transforming how drug candidates are tested and approved — bringing precision, purpose, and innovation to the forefront of biopharma.
Read moreNews
October 25, 2024The Dream Bigger Challenge brought together over 100 Filipino founders, investors, and community champions from across North America to celebrate entrepreneurship and uplift lives through innovation. From dynamic panel talks and breakout sessions to startup pitches competing for $20K in prizes, the event was more than a pitch competition — it was a powerful tribute to the love and sacrifice of those who came before us. As Filipino American entrepreneurs and investors, we carry their legacy forward — building a future where dreaming big knows no bounds, across the U.S., the Philippines, and beyond.
Read morePress Release
July 19, 2023LiVeritas Biosciences has unveiled LiLii™, an advanced AI-powered laboratory ecosystem designed to revolutionize drug development workflows. As a SaaS platform, LiLii™ centralizes project management, CRM, document control, and analytics into a seamless interface — enabling drug developers to process data 15x faster with greater accuracy and transparency. By integrating LiVeritas’ proprietary AI with lab operations, LiLii™ accelerates project setup, enhances data integrity, and reduces reliance on fragmented software. Built by experts in chemistry, engineering, and biopharma, LiLii™ offers scalable, modular solutions for the next generation of analytical testing.
Read more